Author

Kathrin Dieter

Observed name: Dieter, Kathrin

Institution: Rheacell (Germany)

Observed institution: Rheacell (Germany)

ORCID: 0000-0001-6341-4161

Observed ORCID: 0000-0001-6341-4161

OpenAlex ID: A5028054804

Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

2022 · Andreas Kerstan, Kathrin Dieter, et al. · Stem Cell Research & Therapy · 82

Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

2021 · Dimitra Kiritsi, Kathrin Dieter, et al. · JCI Insight · 75

In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials

2019 · Nils Tappenbeck, Hannes M. Schröder, et al. · Cytotherapy · 55

Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data

2020 · Andreas Kerstan, Elke Niebergall-Roth, et al. · Cytotherapy · 48

Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

2021 · Andreas Kerstan, Kathrin Dieter, et al. · JID Innovations · 41

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

2021 · Alexandra Norrick, Jasmina Esterlechner, et al. · Stem Cell Research & Therapy · 38

ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa

2023 · Kathrin Dieter, Elke Niebergall-Roth, et al. · Cytotherapy · 22

Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5+ Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa

2023 · Elke Niebergall-Roth, Kathrin Dieter, et al. · Cells · 10

Systemic treatment of recessive dystrophic epidermolysis bullosa with mesenchymal stromal cells: a scoping review of the literature and conclusions for future clinical research

2024 · Elke Niebergall-Roth, Kathrin Dieter, et al. · Journal of Dermatological Treatment · 3

Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa [Cytotherapy 25 (2023) 782–788/1562]

2023 · Kathrin Dieter, Elke Niebergall-Roth, et al. · Cytotherapy

Works count: 17

Citation count: 374

H-index: 8

I10-index: 8